Literature DB >> 31526646

Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam.

Michael A Rogawski1.   

Abstract

Entities:  

Year:  2019        PMID： 31526646     DOI： 10.1016/j.yebeh.2019.106506

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN： 1525-5050            Impact factor:   2.937


× No keyword cloud information.
  2 in total

Review 1.  Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol.

Authors:  Changqing Xu; Yumin Zhang; David Gozal; Paul Carney
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20

2.  Combined Antiseizure Efficacy of Cannabidiol and Clonazepam in a Conditional Mouse Model of Dravet Syndrome.

Authors:  Shu-Hui Chuang; Ruth E Westenbroek; Nephi Stella; William A Catterall
Journal:  J Exp Neurol       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.